Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

dc.contributor.author	Aguilera Guirao, Antonio
dc.date.accessioned	2017-06-07T07:05:19Z
dc.date.available	2017-06-07T07:05:19Z
dc.date.issued	2013
dc.identifier.issn	1359-6535
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2436
dc.language.iso	eng
dc.title	Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir
dc.type	Artigo	es
dc.authorsophos	Benito, J. M.
dc.authorsophos	Sánchez-Parra, C.
dc.authorsophos	Maida, I.
dc.authorsophos	Aguilera, A.
dc.authorsophos	Rallón, N. I.
dc.authorsophos	Rick, F.
dc.authorsophos	Labarga, P.
dc.authorsophos	Fernández-Montero, J. V.
dc.authorsophos	Barreiro, P.
dc.authorsophos	Soriano, V.
dc.identifier.doi	10.3851/IMP2614
dc.identifier.isi	329761700008
dc.identifier.pmid	23645335
dc.identifier.sophos	13173
dc.issue.number	5
dc.journal.title	ANTIVIRAL THERAPY
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Microbioloxía
dc.page.initial	709
dc.page.final	715
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	18

Files in this item

Files	Size	Format	View
There are no files associated with this item.